Cite
HARVARD Citation
Boronat, M. et al. (n.d.). Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease. Diabetes & vascular disease research. pp. 53-59. [Online].